Related references
Note: Only part of the references are listed.Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study
Cristina Jimenez et al.
ANNALS OF HEMATOLOGY (2018)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D. Phelan et al.
NATURE (2018)
Clonal B cells in Waldenstrom's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling
K. V. Argyropoulos et al.
LEUKEMIA (2016)
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells
Martine van Keimpema et al.
BLOOD (2014)
MYD88 L265P Mutations Are Correlated with 6q Deletion in Korean Patients with Waldenstrom Macroglobulinemia
Jung-Ah Kim et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
Guang Yang et al.
BLOOD (2013)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
A new era for Waldenstrom macroglobulinemia: MYD88 L265P
Steven P. Treon et al.
BLOOD (2013)
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia
Florence Nguyen-Khac et al.
HAEMATOLOGICA (2013)
B-cell receptor signaling as a driver of lymphoma development and evolution
Carsten U. Niemann et al.
SEMINARS IN CANCER BIOLOGY (2013)
Genetic Factors and Pathogenesis of Waldenstrom's Macroglobulinemia
Jorge Monge et al.
CURRENT ONCOLOGY REPORTS (2013)
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia
Lucy S. Hodge et al.
BLOOD (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia
Ghayas C. Issa et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines
Stephen M. Ansell et al.
MAYO CLINIC PROCEEDINGS (2010)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia
Esteban Braggio et al.
CANCER RESEARCH (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
Prognostic Relevance of 6q Deletion in Waldenstrom's Macroglobulinemia: A Multicenter Study
Hong Chang et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
BLIMP1 guides the fate of effector B and T cells
Stephen L. Nutt et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
N. C. Gutierrez et al.
LEUKEMIA (2007)
6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis
E. M. Ocio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
Wee J. Chng et al.
BLOOD (2006)
6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
Roelandt F. J. Schop et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma
X Sagaert et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Lymphoid malignancies: The dark side of B-cell differentiation
AL Shaffer et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program
AL Shaffer et al.
IMMUNITY (2002)
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection
C Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
